Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Airway Alkalinization and Nasal Colonization
NCT03078088Phase 1Completed
- Start
- Jun 2017
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of tromethamine in cystic fibrosis (CF) (2 arms). Primary endpoint: Nasal bacterial colonization at Day 5. Started Jun 2017; status: completed.
02
Drugs
tromethamine
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT03078088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03078088.